Flavocoxid: Difference between revisions
Rabin Bista (talk | contribs) Created page with "__NOTOC__ {{SI}} {{CMG}} == Overview == '''Flavocoxid''' is a brand name for a blend of flavenoids that has recently become a tool in the treatment of osteoarthritis...." |
m Protected "Flavocoxid": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
(No difference)
| |
Latest revision as of 20:58, 18 August 2015
|
WikiDoc Resources for Flavocoxid |
|
Articles |
|---|
|
Most recent articles on Flavocoxid |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Flavocoxid at Clinical Trials.gov Clinical Trials on Flavocoxid at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Flavocoxid
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Flavocoxid Discussion groups on Flavocoxid Patient Handouts on Flavocoxid Directions to Hospitals Treating Flavocoxid Risk calculators and risk factors for Flavocoxid
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Flavocoxid |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Flavocoxid is a brand name for a blend of flavenoids that has recently become a tool in the treatment of osteoarthritis.[1] It is sold under the brand name Limbrel, manufactured by Primus Pharmaceuticals. The capsules also include the ingredient zinc gluconate. Limbrel is used as a nutritional therapy to help reduce inflammation. Flavocoxid has been associated with liver toxicity in prospective clinical trials published in the Annals of Internal Medicine.[2]